JAMA · 1995 · 154 citations · 9 references
Public HealthBiostatisticsCardiologyBayesian BiostatisticsBayesian Data AnalysisEvidence-based PracticeBayesian Clinical TrialsBayesian Decision TheoryBayesian InferenceBayesian ModelingBayesian StatisticsEvidence-based MedicineBayesian AnalysisBayesian Clinical Decision MakingBayesian Trial DesignClinical Trial Design Under Bayesian FrameworkDiagnostic Probability EstimationMyocardial Infarction PharmacotherapyPlasminogen ActivatorsRandomized Clinical Trials
Standard statistical analyses of randomized clinical trials fail to provide a direct assessment of which treatment is superior or the probability of a clinically meaningful difference. A Bayesian analysis permits the calculation of the probability that a treatment is superior based on the observed data and prior beliefs. The subjectivity of prior beliefs in the Bayesian approach is not a liability, but rather explicitly allows different opinions to be formally expressed and evaluated. The usefulness of this approach is demonstrated using the results of the recent GUSTO study of various thrombolytic strategies in acute myocardial infarction. This analysis suggests that the clinical superiority of tissue-type plasminogen activator over streptokinase remains uncertain.
9
D Hunt, George Varigos, F Dienstl et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1992 · 898 citations
Statistical analysis and the illusion of objectivity
Infectious Diseases Newsletter · 1988 · 420 citations